Login / Signup

Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis.

Georgios MakragiannisKaveh VahdaniEster CarreñoRichard W J LeeAndrew D DickAdam H Ross
Published in: International ophthalmology (2017)
Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.
Keyphrases
  • candida albicans
  • diabetic retinopathy
  • biofilm formation
  • pseudomonas aeruginosa
  • combination therapy
  • smoking cessation